Renaissance Technologies’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
+146,600
| New | +$1.96M | ﹤0.01% | 2126 |
|
|
2024
Q3 | – | Sell |
-14,300
| Closed | -$654K | – | 3725 |
|
|
2024
Q2 | $654K | Buy |
+14,300
| New | +$654K | ﹤0.01% | 2561 |
|
|
2023
Q4 | – | Sell |
-43,700
| Closed | -$1.39M | – | 3940 |
|
|
2023
Q3 | $1.39M | Sell |
43,700
-24,700
| -36% | -$787K | ﹤0.01% | 2088 |
|
|
2023
Q2 | $2.75M | Sell |
68,400
-52,700
| -44% | -$2.12M | ﹤0.01% | 1799 |
|
|
2023
Q1 | $5.17M | Buy |
121,100
+29,200
| +32% | +$1.25M | 0.01% | 1460 |
|
|
2022
Q4 | $4.41M | Sell |
91,900
-5,300
| -5% | -$255K | 0.01% | 1588 |
|
|
2022
Q3 | $3.66M | Sell |
97,200
-44,500
| -31% | -$1.67M | 0.01% | 1634 |
|
|
2022
Q2 | $3.92M | Buy |
141,700
+136,400
| +2,574% | +$3.77M | ﹤0.01% | 1739 |
|
|
2022
Q1 | $288K | Buy |
+5,300
| New | +$288K | ﹤0.01% | 3484 |
|
|
2021
Q4 | – | Sell |
-24,572
| Closed | -$972K | – | 4084 |
|
|
2021
Q3 | $972K | Buy |
+24,572
| New | +$972K | ﹤0.01% | 2567 |
|
|
2021
Q1 | – | Sell |
-10,100
| Closed | -$712K | – | 3530 |
|
|
2020
Q4 | $712K | Sell |
10,100
-7,600
| -43% | -$536K | ﹤0.01% | 2671 |
|
|
2020
Q3 | $683K | Buy |
17,700
+11,400
| +181% | +$440K | ﹤0.01% | 2697 |
|
|
2020
Q2 | $236K | Buy |
+6,300
| New | +$236K | ﹤0.01% | 3117 |
|